Two extrinsic fluorescent probes, 3-(dimethylamino)-8,9,10,11-tetrahydro-7H-cyclohepta[a]naphthalen-7-one (1) and 7-(dimethylamino)-2,3-dihydrophenanthren-4(1H)-one (2), are used to probe the unfolding of human serum albumin by sodium dodecyl sulfate (SDS). These probes respond separately to the polarity and H-bond donating ability of their surroundings.
Introduction
Human serum albumin (HSA) is the major protein in blood plasma that is responsible for transportation of hydrophobic molecules throughout the body. 1 HSA contains just over 580 amino acids, only one of which is tryptophan and seventeen of which are tyrosines. It has three α-helical domains designated I, II and III. Each of these domains is further divided into subdomains A and B. Small drug molecules are bound primarily at one of two sites (sites I and II as described by Sudlow) that are located in the A subdomains of II and III. 2, 3 HSA shows high affinity for long alkyl chain anions such as fatty acids and sodium dodecyl sulfate (SDS). 4 Models suggest that these anions bind at the same sites. 5 Crystal structures of HSA-fatty acid complexes reveal that there are seven primary fatty acid binding sites of various topologies. 6, 7 Three of these are high affinity sites. Binding at one of these three sites in particular leads to significant conformation changes in the protein. Fatty acid binding can also affect drug binding at sites I and II.
The intrinsic fluorescence of the single tryptophan (Trp 214) and of extrinsic dyes has been used to report on the physiochemical characteristics of the binding sites and in monitoring HSA unfolding. 8, 9 Following the fluorescence of Trp 214 with added SDS 5,10 reveals four sequential stages or domains during unfolding. 11 In order these stages are for specific binding, non-cooperative binding, cooperative binding and saturation binding. These domains have been documented using a variety of extrinsic fluorophores with bovine serum albumin (BSA), which is structurally similar to HSA. [12] [13] [14] [15] [16] [17] The initial interactions of HSA and BSA with SDS provide some stabilization and protection of the protein. 17, 18 The polarities of the binding sites in the serum albumins have been studied using a variety of fluorescent probes. Most common are molecules that possess an intramolecular chargetransfer excited state (ICT) where the position of the fluorescence emission is affected by the local polarity. [12] [13] [14] 16, [19] [20] [21] [22] [23] [24] Other probes use excited-state intramolecular proton transfer 15, 17, 25, 26 and (ground-state) proton transfer 27, 28 to elucidate the binding site polarity. 29 PRODAN (6-propionyl-2-dimethyaminonaphthalene, Figure 1 ) was prepared by Weber and Farris as an extrinsic fluorescent probe of BSA. 30 PRODAN possesses an ICT excited state, and it has found considerable use as a polarity sensor, especially for lipid bilayers. [31] [32] [33] [34] [35] Drug displacement studies and fluorescent resonance energy transfer studies show that PRODAN binds to site I of HSA. 36, 37 The emission maximum for HSA-bound PRODAN is at 22470 cm −1 , an increase of 3400 cm −1 from its maximum in water. The addition of palmitic acid to the HSA-PRODAN complex initially leads to an increase in fluorescence intensity. At higher concentrations palmitic acid displaces PRODAN from HSA.
Recently we have shown that emission intensities of 1 and 2 ( Figure 1) are strongly quenched by H-bonding interactions. 43, 44 The correlation between the degree of quenching in an alcohol solvent, defined as log(I max /I), and Catalán's solvent acidity parameter SA 41, 45, 46 is very linear. As such, the fluorescence intensity of these compounds can be used as sensors of H-bonding ability. 47, 48 PRODAN derivative 1 senses H-bonding in the upper end of the SA scale, whereas PRODAN regioisomer 2 is sensitive to low solvent acidities. The dual-sensing ability of 1 was used recently to characterize the local acidity of its cyclodextrin complex. 49 In this paper we show that compounds 1 and 2 can be used to shed greater insight into the properties of the HSA binding sites, and, more importantly, changes in the properties of these sites through the specific binding stage of SDS-induced unfolding.
Experimental
Compounds 1 and 2 were prepared previously and sublimed under vacuum before use. 43, 50, 51 Essentially fatty acid free HSA was purchased from Sigma-Aldrich. All solvents used in the solvatochromism studies were spectrophotometric grade except for 2-butanol, 2-hexanol and 2-octanol, which were distilled from Na 0 under N 2 or vacuum. All HSA solutions were made in a 0.05 M phosphate buffer at pH 7.4 in polished water. Fluorescence emission data were collected using a fiber optic system with a 366 nm or 405 nm LED light source and an Ocean Optics Maya CCD detector. Absorption spectra were obtained from the same fiber optic system with a miniature deuterium/tungsten light source. Relative molar absorptivities were determined by the method of standard additions. 48 Binding isotherm data were generated from the emission spectra of a series of aqueous solutions at 23°C in which the fluorophore concentration was held constant and the HSA concentration was varied. The following procedure was typical: 10-20 μL of a stock solution of fluorophore (ca. 5 mg/10 mL ROH) and a variable volume (0 to 5000 μL) of a stock solution of HSA (ca. 180-360 mg/ 50 mL buffer) were diluted to 5 mL with buffer. Reference solutions of the same concentration of fluorophore in the various alkanols were also prepared. Raw fluorescence intensities were adjusted to account for the detector spectral response and for the conversion from wavelength to wavenumbers. 48, 52 Plots of the integrated intensity ( ) dṽ) vs.
[HSA] were fit to equation 1 using non-linear least squares. The limiting intensity of the plot, I L ,is the intensity of the fluorophore-HSA complex, while is the emission factor ratio between the fluorophore solvated in water and complexed with HSA. This factor accounts for differences in the absorption at the excitation wavelength and in the relative quantum yields (equation 2). The emission center-of-mass was calculated as ṽ CM = ∫I(ṽ)•ṽ dṽ/∫I(ṽ) dṽ. The binding sites on HSA for 1 and 2 are established through competitive binding studies. The competitive binders for site I and site II are warfarin for site I (K = 3.4 × 10 5 M −1 ) and S-naproxen for site II (K = 3.7 × 10 6 M −1 ). 53 Both of these drugs have higher affinity towards HSA than does either 1 or 2. Figure 3 shows that both compounds are displaced by one drug but not the other. For compound 1 the addition of warfarin causes a significant decrease in the intensity without altering ṽ CM . On the other hand, naproxen induces only a small but variable change in the intensity, but a decrease of over 200 cm −1 in ṽ CM . For 2 the addition of naproxen causes an even greater decrease in intensity compared to the effect of added warfarin on 1-HSA, while the addition warfarin actually leads to an increase in fluorescence. These results suggest that 1 binds to site I, whereas 2 binds to site II. PRODAN is reported to bind to site I. 36 PROMEN (6-propionyl-2-methoxynaphthalene), while structurally very similar to PRODAN, is reported to bind to Site II. 29, 54 Results from Green The microacidity-sensing abilities of these compounds are based on the strong quenching that they suffer in protic solvents as a result of H-bonding interactions. 47, 48 The acidity determinations are made by comparing the fluorescence intensities of the complexes and with the intensities of the fluorophores in several reference solvents. The fluorescence intensities of the complexes are given by the limiting intensities from the binding isotherms (I L in eqn 1). The intensities are converted to relative quantum yields by adjusting for the differing molar absorptivities at the excitation wavelengths and the differing indices of refraction. Compound 1 is sensitive to solvent acidity in the range of isopropanol (SA=0.283) to water (SA=1.062), whereas compound 2 responds to acidities less than that of ethanol (SA=0.4). For 1-HSA the relative quantum yield is nearly as great as that of 1 in isopropanol (data not shown) in which there is little quenching. Because the ṽ CM value for the 1-HSA complex indicates an effective polarity that is much less than that of isopropanol, it is likely that the effective solvent acidity is also less than that of isopropanol (0.28). That is, the acidity of 1-HSA is below the range that 1 is able to sense.
The calibration curve for the solvent acidity determination of the 2-HSA complex is shown in Figure 5 . Previously, the range of solvent acidities was determined only with a lower bound of 0.145 (t-butanol). 48 For the current study, the range is extended with references at 0.14 (2-hexanol), 0.88 (2-octanol) and 0.0 (toluene). The y-intercept of the best fit line of the plot of log(Φ 2-HSA /Φ ROH ) vs. the solvent acidity parameter determines the effective acidity of the 2-HSA complex. The intercept is nearly at the toluene reference point, and the effective acidity is calculated to be 0.01. This number is extremely low, and it is likely that it is only a lower bound. Without H-bonding interactions to deactivate the fluorescence of 2, the influence of other factors, like the reduced collisional coupling with its surroundings and incomplete dipolar relaxation, will lead to greater fluorescence than in isotropic solution. 60 Greater fluorescence intensity will translate as a lower effective solvent acidity. On the other hand, the ṽ CM value for the complex (18790 cm −1 ) is much closer to the ṽ CM value for 2 in toluene (19680 cm −1 ) than for 2 in 2-octanol (17310 cm −1 ), suggesting that a low effective SA assignment is warranted. These results suggest that 1 and 2 have very little exposure to the surrounding water.
These two sensors shed light on the beginning of the denaturation process with the detergent SDS in the specific binding range. In this binding domain each molecule of SDS binds successively to HSA until the HSA host is saturated. After that, the SDS molecules bind in a non-cooperative manner. The saturation limit occurs with ~seven molecules of SDS. Figure  6 shows the titration of the HSA complexes with SDS. The mole ratio of the SDS with HSA (based on concentrations) is used as the abscissa, and HSA is used in 100% excess of either fluorophore. The effect of SDS on the fluorescence intensity of the 1-HSA complex ( Figure  6A ) is what is often observed with other fluorophores; that is, addition of SDS causes an increase in the fluorescence. The maximum intensity is reached at the end of the specific binding domain. While the fluorescence intensity is increasing, the fluorescence center-ofmass exhibits sigmoidal behavior. It increases slightly through two equivalents of SDS, then it sharply declines until the titration reaches seven equivalents of SDS. The change in the ṽ CM value amounts to 690 cm −1 , and ṽ CM shifts to 20450 cm −1 . Part of the increase in fluorescence intensity is due to stronger binding. With six equivalents of SDS the binding constant increases to 5.0 × 10 5 M −1 ( Figure 2 ). The ṽ CM values in the binding isotherm in Figure 2 show that the ratio of bound SDS to HSA does not drop even at low HSA concentrations. If they did, the ṽ CM values would increase according to the behavior seen in Figure 6 . Instead, they decrease due to the contribution of free 1 in solution. The remainder of the increase in fluorescence is due to an increase in the quantum yield in the 1-HSA-SDS n complex. The fluorescence quantum yield of compound 1 is known to increase with increasing solvent polarity due to optimal formation of the intramolecular charge transfer state. By comparison the ṽ CM value for 1 in isopropanol is 20200 cm −1 . Thus, 1 experiences a significant increase in polarity through the specific binding region of denaturation. Because the ṽ CM is still greater than that in isopropanol, the effective acidity surrounding 1 may still be too low to be sensed by 1. Thus, it is not clear whether the increase in polarity is associated with an increase in solvent exposure.
Even though 2 binds at a different site than 1, it also experiences a significant increase in polarity (Δṽ CM = 820 cm −1 ) through the specific binding domain ( Figure 6B ). In contrast to 1, the fluorescence intensity decreases precipitously after an initial increase. The decrease in intensity is associated with a decrease in ṽ CM , and hence an increase in polarity. The drop in fluorescence intensity is not due to dislodgement by SDS. As with 1, the binding of 2 by HSA increases three-fold with SDS complexation (from 5.0 × 10 5 M −1 to 1.5 × 10 6 M −1 , Figure 2 ). Again, because ṽ CM does not vary during the titration, the stoichiometry of the HSA-SDS n complex must remain nearly constant. In this case, the drop in fluorescence intensity can be ascribed to deactivation by H-bonding. When the SDS titration is done in D 2 O buffer, the decrease in intensity is significantly less ( Figure 6B While the D 2 O results are definitive for establishing the mode of deactivation for 2 in the HSA-SDS n complex, there is still the possibility that SDS induces a dislocation of the fluorophore from one binding site to another, 61 one where the second site is more solvent accessible. This possibility can be addressed by titrating ternary complexes, one with a competitive binder in the free primary drug site and the other with a competitive binder that displaces 1 or 2 from their preferred site. Figure 7 shows the SDS titration of 1-HSA with warfarin and naproxen. The initial ṽ CM for the ternary complexes are ~600 cm −1 lower than for the binary complexes. Warfarin should dislocate 1 from site I. While the decrease in ṽ CM is similar to that without warfarin, its onset is sooner, and it is accompanied by an early onset of the maximum fluorescence intensity at ~two SDS equivalents. Naproxen should block site II from any dislocation of 1 from site I. Just as is seen in Figure 6 without naproxen, ṽ CM decreases after an initial increase, and it reaches the same minimum at ~20600 cm −1 . The increase in fluorescence intensity shows as similar maximum position at ~five SDS equivalents. While these results are mixed, they suggest that 1 does not dislocate from site I to site II during titration with SDS.
The results are more definitive with the SDS titrations of the 2-HSA-drug ternary complexes. Figure 8A shows that the 2-HSA-warfarin complex behaves just like the 2-HSA complex. Both the intensity and ṽ CM reach a maximum at two equivalents of SDS, then decrease quickly. While the 2-HSA-naproxen complex shows similar behavior in the fluorescence intensity, the ṽ CM does not show the same initial increase through two equivalents of SDS. These results suggest that 2 does not dislocate from site II to site I during the SDS titration.
From the calibration curve in Figure 5 the increase in quenching for the 2-HSA-SDS n complex can be correlated with an increase in SA of 0.10. This value corresponds to a solvent that has stronger H-bond donation than 2-octanol. On the other hand, the ṽ CM value for the complex is 18200 cm −1 , but the ṽ CM for 2 in 2-octanol is only 17300 cm −1 . The increase in H-bond quenching is greater than the increase in polarity as measured by the ṽ CM value. This disparity suggests that the 2-HSA-SDSn complex undergoes significant changes as the number of bound SDS molecules increases. These changes are either in the protein conformation itself or possibly in the orientation of 2 in the binding pocket. Unlike site I which faces subdomain IIIA, the opening to site II is known to be exposed to the solvent. 62 Either way, the result is much greater exposure of the carbonyl oxygen to the solvent, while the rest of the fluorophore remains fairly protected in a hydrophobic pocket. The increase in effective polarity can be explained in part, if not entirely, by the greater exposure to solvent.
In conclusion, dual fluorescent sensors 1 and 2 reveal facets of the initial phase of denaturation of human serum albumin through the specific binding region. Both sensors show that the respective binding sites become less polar with two equivalents of SDS. With additional equivalents the polarity of both sites increases dramatically until the beginning of the noncooperative binding region. Compound 1, being sensitive to H-bonding in environments with effective solvent acidity greater than that of isopropanol, is not able to discern whether the polarity increase is due to greater solvent exposure. For compound 2, the increase in effective polarity is due to solvent exposure as shown by the significant Hbonding induced fluorescence quenching.
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